Owner: Director of Quality
Class: Planning Document (Class 4)
Status: Active — Pending sign-off
Last Updated: 2026-05-07
Cycle: 2026-05-05__release-v3.2

---

# Delivery Verification Report — 2026-05-05__release-v3.2

---

## §1 — Verification Status

```
Status: Verified
Sprint goal: Ship the Pre-Trade Research View (PT-02) and Prospective Heat integration (PT-03)
            in Sprint 1 and the Pre-Trade Entry Checklist (PT-05) in Sprint 2, completing Arc 2's
            primary user-value deliverables, while clearing four v3.1 governance deferred actions
            and five documentation/security backlog items.
Cycle: 2026-05-05__release-v3.2
Backlog slice source: claude/cycles/2026-05-05__release-v3.2/stage4_backlog_slice.md (original, no amendment)
Verification run: 2026-05-07T00:00:00Z
```

**Sprint goal: MET — all 17 stories delivered.**

---

## §2 — Traceability Matrix

All 17 stories are tracked in `execution_state.json` with `status: done`, `acceptance_verified: true`, `deviations_filed: true`. Zero items returned to backlog.

| ST Item | Title | Outcome | Spec Reference | Backlog Entry |
|---------|-------|---------|---------------|---------------|
| ST-01 | Pre-trade research view component — data display | done | docs/specs/frontend/pages/research.md | N/A |
| ST-02 | Trade plan context panel in research view | done | docs/specs/frontend/pages/research.md | N/A |
| ST-03 | Prospective heat at entry metric integration (PT-03) | done | docs/specs/api_contracts/pre_trade_research_endpoints.md | N/A |
| ST-04 | Navigation integration — screener and watchlist entry points | done | docs/specs/frontend/pages/screener_results.md; watchlist.md | N/A |
| ST-05 | Entry checklist schema, component, and Trade Plan form integration | done | docs/specs/frontend/pages/trade_plan.md#Entry Checklist | N/A |
| ST-06 | Checklist pre-population from trade plan data and research view link | done | docs/specs/frontend/pages/trade_plan.md#Entry Checklist | N/A |
| ST-07 | sprint_planning_prompt.md STEP 0 main-branch verification | done | claude/system/sprint_planning_prompt.md | N/A |
| ST-08 | execution_prompt.md STEP 5.1 deviations_filed enforcement | done | claude/system/execution_prompt.md#STEP 5.1 | N/A |
| ST-09 | execution_prompt.md §3.1.A test_scenarios post-story advisory | done | claude/system/execution_prompt.md#§3.1.A | N/A |
| ST-10 | Playwright waitFor pattern — test authoring standard | done | claude/system/execution_prompt.md#§14 | N/A |
| ST-11 | Trade Plan domain test scenario registration (TEST-GAP-EPIC-01) | done | tests/e2e/trade-plan.spec.js (SC-TP-01–07) | N/A |
| ST-12 | Earnings Calendar and UK screener test registration (TEST-GAP-EPIC-03) | done | tests/e2e/earnings-calendar.spec.js; tests/e2e/screener-uk-suffix.spec.js | N/A |
| ST-13 | React component inventory (BLG-FE-16) | done | docs/specs/frontend/component_inventory.md | N/A |
| ST-14 | Design system document (BLG-FE-21) | done | docs/specs/frontend/design_system.md | N/A |
| ST-15 | Alpaca credential audit and rotation policy (BLG-SEC-05) | done | docs/ops/alpaca_key_rotation_policy.md | N/A |
| ST-16 | External API dependency risk register (BLG-GOV-18) | done | docs/ops/external_api_dependency_register.md | N/A |
| ST-17 | Cycle artefact inventory and maintenance review (BLG-GOV-11) | done | claude/system/OPERATIONAL_GUIDE.md §16 | N/A |

**Traceability gaps: 0 | Items returned: 0 | Backlog entries added this run: 0**

**Advisory:** `spec_references` field absent from `execution_state.json` for ST-01 through ST-04 and ST-07 through ST-17. All spec references are documented in `sprint_close.md` (Items Done table). Minor traceability advisory — standard mode proceeds. No action required this cycle.

---

## §3 — QA Evidence Summary

| EPIC | Stories | Sign-off Authority | Date | Overall Result | Notes |
|------|---------|-------------------|------|----------------|-------|
| EPIC-01 | ST-01/02/03/04 | Director of Quality (re-verification) | 2026-05-06 | Pass | Initial sign-off by Sprint Execution Engine (autonomous class) was Tier 2 non-compliant (criterion 3: frontend-visible changes). P1 staging deviations identified and resolved in commit 9de18442. DoQ re-verification 14/14 Playwright pass. |
| EPIC-02 | ST-05/06 | Director of Quality | 2026-05-06 | Pass | 11 AC pass by code review. BLG-QA-14 filed per LL-v3.1-EX-01 for 7 observable ACs (Playwright target v3.3). |
| EPIC-03 | ST-07–12 | Director of Quality | 2026-05-06 | Pass | 21/21 Playwright pass (SC-TP-01–07, SC-EARN-01–09, SC-UK-01–04). Governance stories ST-07–10 code-review-verified. |
| EPIC-04 | ST-13–17 | Sprint Execution Engine (autonomous class BLG-GOV-19) | 2026-05-06 | Pass | All 4 BLG-GOV-19 criteria met: all autonomous, all AC code-review-verifiable, no frontend-visible changes, engine signer populated. Documentation stories only. |

**STEP -1.3 compliance note:** EPIC-01 original sign-off (Sprint Execution Engine, autonomous class) triggered Tier 2 review at preflight. Criterion 3 (no frontend-visible change) was not met. DoQ declined Tier 2 counter-sign pending P1 engineering fixes. After fixes (commit 9de18442, 14/14 Playwright pass), DoQ issued authoritative re-verification sign-off. Tier 2 compliance resolved. EPIC-04 autonomous class sign-off verified compliant — all 4 criteria met.

All sign-off blocks complete. All AC Pass. No QA Fail results in any EPIC.

---

## §4 — Deviation Register

**No spec deviations filed this sprint.** `deviations_filed = true` for all 17 stories per execution_state.json. sprint_close.md confirms zero deviations.

**Note on staging findings:** DEV-E01-01 through DEV-E01-04 (identified during delivery verification preflight by Director of Quality) were QA findings, not canonical spec deviations. All were resolved in commit 9de18442 before re-verification. The P3 finding DEV-E01-03 (UK `.L` suffix) was fixed in the same commit. These are not filed as spec deviations — they are implementation quality issues resolved before the sprint closes to this verification.

| Deviation Ref | ST Item | Priority | Description | Disposition | Backlog Item |
|---------------|---------|----------|-------------|-------------|-------------|
| — | — | — | No canonical spec deviations filed this sprint | — | — |

**Hard blocks section:** None.

**Acceptance records section:** N/A (no P1/P2 deviations requiring acceptance).

---

## §5 — Outstanding Items and Deferred Execution Blockers

### 5a — Outstanding Items Carried to Backlog

All delegated items closed at sprint close:
- DEL-20260506-01 (ST-11): Completed — Director of Quality sign-off 2026-05-06
- DEL-20260506-02 (ST-12): Completed — Director of Quality sign-off 2026-05-06

No outstanding items carried forward. Nothing to add to backlog.

### 5b — Deferred Execution Blocker Dispositions

`deferred_execution_blockers = []` per `state.json`. No deferred execution blockers were accepted at sprint planning time. Field confirmed empty.

### 5c — Stale Parked Items

The `stage4_backlog_slice.md` contains only active sprint items (ST-01 through ST-17) — no parked items present in the authoritative backlog slice. Stale parked item detection: N/A for this cycle.

---

## §6 — Test Coverage Assessment

### EPIC-01

- Scenarios: `tests/e2e/pre-trade-research.spec.js` SC-RES-01 to SC-RES-13 (14 tests)
- Status: 14/14 passed (21.9s) — 2026-05-06
- Coverage: All observable AC covered by Playwright tests.
- Gap: None.

### EPIC-02

- Scenarios: None — `tests/e2e/entry-checklist.spec.js` pending (BLG-QA-14, target v3.3)
- Status: 0 Playwright tests executed for EPIC-02 this cycle. Code review only.
- Coverage gap: 7 observable ACs (SC-CL-01 through SC-CL-07) lack Playwright coverage.

## Test Coverage Gap — EPIC-02: Pre-Trade Entry Checklist

**Gap type:** No Playwright scenarios — code review only for observable ACs
**Spec sections covered:** `docs/specs/frontend/pages/trade_plan.md#Entry Checklist`
**ACs not covered by Playwright:**
- SC-CL-01: Checklist renders in Trade Plan form with 4 default items
- SC-CL-02: Items can be toggled (checked/unchecked)
- SC-CL-03: State persists on save (round-trip via PUT /trade-plans/{id})
- SC-CL-04: Pre-population — stop_defined pre-checked when early_exit_conditions present
- SC-CL-05: Pre-population — research_reviewed pre-checked when r_target set
- SC-CL-06: Review research link navigates to /research/{ticker}
- SC-CL-07: Read-only checklist renders in Research view trade plan panel

**Action required:** QA & Testing Owner to author `tests/e2e/entry-checklist.spec.js` in v3.3.
Backlog item: BLG-QA-14 (already filed 2026-05-06).

### EPIC-03

- Scenarios: SC-TP-01–07 (8 tests), SC-EARN-01–09 (9 tests), SC-UK-01–04 (4 tests)
- Status: 21/21 passed — 2026-05-06
- Coverage: Complete.

### EPIC-04

- Scenarios: None required (documentation stories only — no UI changes)
- Status: Not applicable.

### Test Scenario Gaps — Structured Register

| gap_id | EPIC | Description | Qualifying reason | Disposition |
|--------|------|-------------|-------------------|-------------|
| TSG-v32-01 | EPIC-02 | Entry checklist component: 7 observable ACs (SC-CL-01 to SC-CL-07) lack Playwright coverage | Core user journey — entry checklist is primary PT-05 deliverable; no Playwright scenario covers form rendering, toggle, save, pre-population, or research link | backlog_item_created — BLG-QA-14 |

---

## §7 — System Status Confirmation

`docs/System_status_report.md` reviewed — v3.2 section present with all 4 EPICs correctly listed under "Capabilities now live". "Verification inputs ready" row updated from `Pending` to `✅ Verified 2026-05-07`. No capability discrepancies found. No corrections required beyond the verification status update.

---

## §9 — Sign-off Block

## Director of Quality Sign-off

- [x] Traceability complete (all 17 items traced; spec_references advisory noted — not blocking)
- [x] QA evidence reviewed and accepted (all 4 EPICs Pass; EPIC-01 re-verification complete; EPIC-02 BLG-QA-14 acknowledged)
- [x] Deviation register reviewed; no P0/P1/P2 deviations; zero deviation register is correct
- [x] Test coverage gaps actioned (TSG-v32-01 → BLG-QA-14 filed)
- [x] System status report confirmed accurate (v3.2 section complete; verification status updated)
- [x] Deferred execution blockers dispositioned (none this cycle — field empty)

Signed off by: Director of Quality
Date: 2026-05-07
Comments: All 17 stories delivered. Zero spec deviations. EPIC-01 P1 staging findings resolved before verification — this is the correct sequence and the DoQ review process functioned as intended. The autonomous class misapplication for EPIC-01 was caught at STEP -1.3 Tier 2 and resolved through the proper counter-sign/re-verify path. TSG-v32-01 acknowledged — BLG-QA-14 already filed. Verification status: Verified.

## Product Owner Acceptance

- [x] Outstanding items confirmed in backlog
- [x] P1/P2 deviation acceptances confirmed (none this cycle)
- [x] Deferred execution blocker outcomes acknowledged (none this cycle)
- [x] Next cycle cleared to open

Accepted by: Product Owner
Date: 2026-05-07
Comments: Sprint goal met. All Arc 2 primary deliverables (PT-02, PT-03, PT-05) live. Four governance deferred actions cleared. Five documentation/security items cleared. BLG-QA-14 (Playwright for entry checklist) deferred to v3.3 — acceptable. BLG-FE-23–27 filed from staging review — P3/design items, non-blocking. Next cycle may open.
